Bristol Myers’s stock pops as earnings top estimates and company raises guidance

• Biogen’s stock hit by soft sales of Alzheimer’s treatment

  Business - MarketWatch - 23 hours ago

• Pfizer’s earnings crush estimates as company raises guidance

  Business - MarketWatch - 2 days ago

• Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs

  Business - CNBC - 1 hour ago

• Merck’s stock slides as Q3 earnings beat estimates, but company lowers guidance

  Business - MarketWatch - 55 minutes ago

• Centene’s stock soars 11% after earnings sweep past estimates and company backs guidance

  Business - MarketWatch - 6 days ago

• Comcast tops earnings estimates as Olympics propel the company

  Business - CNBC - 1 hour ago

• Peloton’s stock soars after company names Apple Fitness+ co-founder as new CEO

  Business - MarketWatch - 1 hour ago

More from MarketWatch

• ‘I became very frugal’: My husband and I are 40. I have $200,000 in student debt, while he has $600,000 in retirement savings. Are we in trouble?

  Business - MarketWatch - 8 minutes ago

• ‘Sorry, not sorry’: I don’t have kids and I’m not spending a fortune on candy this Halloween. Does that make me a bad person?

  Business - MarketWatch - 21 minutes ago

• Need a break from election angst? Here’s what’s worth streaming in November 2024.

  Business - MarketWatch - 25 minutes ago

• Mastercard’s stock turns lower but analyst highlights this encouraging trend

  Business - MarketWatch - 32 minutes ago

• ‘DJT’ stock has seen ‘aggressive’ selling by retail investors leading into election

  Business - MarketWatch - 41 minutes ago